Briacell Therap (BCTX) Competitors $9.15 +0.07 (+0.77%) Closing price 04:00 PM EasternExtended Trading$9.21 +0.06 (+0.66%) As of 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCTX vs. SNYR, QTTB, NAII, CTXR, AYTU, FNCH, LEXX, CING, LIXT, and HOTHShould you be buying Briacell Therap stock or one of its competitors? The main competitors of Briacell Therap include Synergy CHC (SNYR), Q32 Bio (QTTB), Natural Alternatives International (NAII), Citius Pharmaceuticals (CTXR), Aytu BioPharma (AYTU), Finch Therapeutics Group (FNCH), Lexaria Bioscience (LEXX), Cingulate (CING), Lixte Biotechnology (LIXT), and Hoth Therapeutics (HOTH). These companies are all part of the "pharmaceutical products" industry. Briacell Therap vs. Its Competitors Synergy CHC Q32 Bio Natural Alternatives International Citius Pharmaceuticals Aytu BioPharma Finch Therapeutics Group Lexaria Bioscience Cingulate Lixte Biotechnology Hoth Therapeutics Briacell Therap (NASDAQ:BCTX) and Synergy CHC (NASDAQ:SNYR) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Which has stronger valuation & earnings, BCTX or SNYR? Synergy CHC has higher revenue and earnings than Briacell Therap. Briacell Therap is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriacell TherapN/AN/A-$4.79M-$83.18-0.11Synergy CHC$34.83M0.65$2.12M$0.386.32 Is BCTX or SNYR more profitable? Synergy CHC has a net margin of 10.02% compared to Briacell Therap's net margin of 0.00%. Synergy CHC's return on equity of -18.56% beat Briacell Therap's return on equity.Company Net Margins Return on Equity Return on Assets Briacell TherapN/A -479.97% -182.26% Synergy CHC 10.02%-18.56%20.28% Do insiders & institutionals hold more shares of BCTX or SNYR? 15.4% of Briacell Therap shares are owned by institutional investors. 5.7% of Briacell Therap shares are owned by insiders. Comparatively, 56.6% of Synergy CHC shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer BCTX or SNYR? Briacell Therap presently has a consensus target price of $320.00, suggesting a potential upside of 3,397.27%. Synergy CHC has a consensus target price of $10.00, suggesting a potential upside of 316.67%. Given Briacell Therap's higher possible upside, research analysts plainly believe Briacell Therap is more favorable than Synergy CHC.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Briacell Therap 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Synergy CHC 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Does the media favor BCTX or SNYR? In the previous week, Synergy CHC had 3 more articles in the media than Briacell Therap. MarketBeat recorded 4 mentions for Synergy CHC and 1 mentions for Briacell Therap. Briacell Therap's average media sentiment score of 0.99 beat Synergy CHC's score of 0.25 indicating that Briacell Therap is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Briacell Therap 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Synergy CHC 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummarySynergy CHC beats Briacell Therap on 11 of the 14 factors compared between the two stocks. Get Briacell Therap News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BCTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTX vs. The Competition Export to ExcelMetricBriacell TherapMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.22M$3.13B$5.76B$10.41BDividend YieldN/A2.37%5.74%4.63%P/E Ratio-0.1120.5976.5226.72Price / SalesN/A385.20496.69161.98Price / CashN/A45.3237.1760.63Price / Book-0.429.6513.716.39Net Income-$4.79M-$53.02M$3.29B$271.62M7 Day Performance14.38%1.03%0.92%2.76%1 Month Performance27.08%7.85%6.19%9.54%1 Year Performance-89.87%10.32%81.04%31.52% Briacell Therap Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXBriacell Therap2.7309 of 5 stars$9.15+0.8%$320.00+3,397.3%-88.4%$6.22MN/A-0.118Positive NewsSNYRSynergy CHC3.9763 of 5 stars$2.24-2.2%$10.00+346.4%N/A$21.62M$34.83M5.8940QTTBQ32 Bio2.1995 of 5 stars$1.78+1.7%$12.17+583.5%-96.3%$21.35M$1.16M-0.4139NAIINatural Alternatives InternationalN/A$3.34-2.2%N/A-49.5%$21.07M$113.80M-2.40290Upcoming EarningsCTXRCitius Pharmaceuticals1.937 of 5 stars$1.21-0.8%$53.00+4,280.2%-90.8%$20.76MN/A0.0020Short Interest ↑AYTUAytu BioPharma3.669 of 5 stars$2.33+2.6%$10.00+329.2%-4.0%$20.38M$81M-3.24160Upcoming EarningsHigh Trading VolumeFNCHFinch Therapeutics GroupN/A$12.67-0.2%N/A+6.5%$20.35MN/A-1.44190Gap DownLEXXLexaria Bioscience3.3236 of 5 stars$1.00-3.9%$4.00+300.1%-62.1%$20.34M$460K-1.497News CoverageShort Interest ↓CINGCingulate2.7155 of 5 stars$3.86+2.9%$26.25+580.1%-28.7%$20.30MN/A-0.9420LIXTLixte Biotechnology0.9027 of 5 stars$4.80+11.1%N/A+171.0%$19.73MN/A-3.724HOTHHoth Therapeutics2.4166 of 5 stars$1.46-0.7%$4.00+174.0%+90.1%$19.49MN/A-1.364Gap Up Related Companies and Tools Related Companies SNYR Alternatives QTTB Alternatives NAII Alternatives CTXR Alternatives AYTU Alternatives FNCH Alternatives LEXX Alternatives CING Alternatives LIXT Alternatives HOTH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BCTX) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Briacell Therap Please log in to your account or sign up in order to add this asset to your watchlist. Share Briacell Therap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
